Page 67 - JSOM Fall 2021

-learning-network/diagnostics/RT-pcr-testing/#Guidelines. Accessed 17. Kontou PI, Braliou GG, Dimou NL, et al. Antibody tests in
25 May 2021. detecting SARS-CoV-2 infection: a meta-analysis. Diagnostics
3. Chau CH, Strope JD, Figg WD. COVID-19 clinical diagnostics ( Basel). 2020;10(5):319.
and testing technology. Pharmacotherapy. 2020;40(8):857–868. 18. Lu H, Stratton C, Tang Y-W. An evolving approach to the lab-
4. Centers for Disease Control and Prevention (CDC). Coronavirus oratory assessment of COVID-19. J Med Virol. 2020;92(10):
disease 2019 (COVID-19): Interim Guidelines for collecting, han- 1812–1817.
dling, and testing clinical specimens from persons for Corona virus 19. Muench P, Jochum S, Wenderoth V, et al. Development and vali-
Disease 2019 (COVID-19). 26 February 2021.) https://www.cdc dation of the Elecsys anti-SARS-CoV-2 immunoassay as a highly
.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens specific tool for determining past exposure to SARS-CoV-2. J Clin
.html. Accessed 25 May 2021. Microbiol. 2020;58(10).
5. Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS- 20. Wajnberg A, Mansour M, Leven E, et al. Humoral immune re-
CoV-2 in patients with novel coronavirus disease 2019. Clin In- sponse and prolonged PCR positivity in a cohort of 1343 SARS-
fect Dis. 2020;71(16):2027–2034. CoV 2 patients in the New York City region [Preprint]. medRxiv.
6. Mathur G, Mathur S. Antibody testing for COVID-19. Am J Clin 5 May 2020.
Pathol. 2020;154(1):1–3. 21. Cervia C, Nilsson J, Zurbuchen Y, et al. Systemic and mucosal
7. La Marca A, Capuzzo M, Paglia T, et al. Testing for SARS-CoV-2 antibody responses specific to SARS-CoV-2 during mild versus se-
(COVID-19): a systematic review and clinical guide to molecular vere COVID-19. J Allergy Clin Immunol. 2021;147(2):545–557.
and serological in-vitro diagnostic assays. Reprod Biomed On- e9.
line. 2020;41(3):483–499. 22. Kellam P, Barclay W. The dynamics of humoral immune responses
8. Weiss S, Wormser G. COVID-19: Understanding the science of following SARS-CoV-2 infection and the potential for reinfection.
antibody testing and lessons from the HIV epidemic. Diagn Mi- J Gen Virol. 2020 Aug;101(8):791–797.
crobiol Infect Dis. 2020;98(1):115078. 23. Wellinghausen N, Voss M, Ivanova R, et al. Evaluation of the
9. Roche Molecular Systems. Cobas SARS-CoV-2. https://www.fda SARS-CoV-2-IgG response in outpatients by five commercial im-
.gov/media/136049/download. Accessed 25 May 2021. munoassays. GMS Infect Dis. 2020;8:Doc22.
10. Army Publishing Directorate. FM 3-90-1. 22 March 2013. Army 24. Chan CW, Parker K, Tesic V, et al. Analytical and clinical eval-
Publishing Directorate. https://armypubs.army.mil/ProductMaps/ uation of the automated Elecsys anti-SARS-CoV-2 antibody as-
PubForm/Details.aspx?PUB_ID=103287. Accessed 25 May 2021. say on the Roche cobas e602 analyzer. Am J Clin Pathol. 2020;
11. Long QX, Tang XJ, Shi QL, et al. Clinical and immunological 154(5):620–626.
assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 25. Egger M, Bundschuh C, Wiesinger K, et al. Comparison of the
2020;26(8):1200–1204. Elecsys anti-SARS-CoV-2 immunoassay with the EDI enzyme
™
®
12. Ibarrondo FJ, Fulcher JA, Goodman-Meza D, et al. Rapid decay linked immunosorbent assays for the detection of SARS-CoV-2
of anti-SARS-CoV-2 antibodies in persons with mild COVID-19 antibodies in human plasma. Clin Chim Acta. 2020;509:18–21.
[published correction appears in N Engl J Med. 2020 Jul 23. N 26. Gunnarsdóttir HD, Sinha MS, Gerke S, Minssen T. Applying the
Engl J Med. 2020;383(11):1085–1087. proportionality principle to COVID-19 antibody testing. J Law
13. Wajnberg A, Amanat F, Firpo A, et al. Robust neutralizing an- Biosci. 2020;7(1):lsaa058. Published 4 Aug 2020.
tibodies to SARS-CoV-2 infection persist for months. Science. 27. Jiang JC, Zhang Y. Serological antibody testing in the COVID-19
2020;370(6521):1227–1230. pandemic: their molecular basis and applications. Biochem Soc
14. Kaye R, Chang CWD, Kazahaya K, et al. COVID-19 anosmia re- Trans. 2020;48(6):2851–2863.
porting tool: initial findings. Otolaryngol Head Neck Surg. 2020; 28. Randad PR, Pisanic N, Kruczynski K, et al. COVID-19 serology
163(1):132–134. at population scale: SARS-CoV-2-specific antibody responses in
15. Peyrony O, Marbeuf-Gueye C, Truong V, et al. Accuracy of emer- saliva. Preprint. medRxiv. 2020;2020.05.24.20112300. Published
gency department clinical findings for diagnosis of coronavirus 2020 May 26.
disease 2019. Ann Emerg Med. 2020 Oct;76(4):405–412.
16. Ravi N, Cortade DL, Ng E et al. Diagnostics for SARS-CoV-2
detection: a comprehensive review of the FDA-EUA COVID-19
testing landscape. Biosens Bioelectron. 2020;165:112454.

COVID-19 Antibody Prevalence in Army Infantry Brigade | 65